Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
About Anatomic Pathology Testing
The anatomic pathology testing helps in identifying abnormalities in tissue or cell lines and develops personalized care treatment. It helps to evaluate different types of cancers such as lung cancer, breast cancer, colorectal cancer, and chronic conditions such as kidney or liver disease, infectious disease, and autoimmune diseases.
Technavio’s analysts forecast the global anatomy pathology testing market to grow at a CAGR of 8.26% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global anatomy pathology testing market for 2017-2021. To calculate the market size, the report considers the revenue generated from anatomy pathology testing.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Anatomic Pathology Testing Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Abbott Diagnostics
• Agilent Technologies
• Danaher
• Roche Diagnostics
• Thermo Fisher Scientific
Other prominent vendors
• 20/20 GeneSystems
• Abcam
• AdnaGen
• Advanced Cell Diagnostics
• Agendia
• Angsana Molecular & Diagnostics Laboratory
• AutoGenomics
• Biocare Medical
• Biocartis
• CellMax Life
• Cancer Genetics
• Digipath
• Enzo Biochem
• Epic Sciences
• Janssen Diagnostic
• Monogram Biosciences
• Nucleix
• Omnyx
• Oxford Cancer Biomarkers
• RareCyte
• SAKURA FINETEK USA
• Tecan
• VolitionRx
Market driver
• Growing prevalence of cancer in demographics
• For a full, detailed list, view our report
Market challenge
• High initial investment and maintenance costs
• For a full, detailed list, view our report
Market trend
• Presence of venture capitalists in market
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
The anatomic pathology testing helps in identifying abnormalities in tissue or cell lines and develops personalized care treatment. It helps to evaluate different types of cancers such as lung cancer, breast cancer, colorectal cancer, and chronic conditions such as kidney or liver disease, infectious disease, and autoimmune diseases.
Technavio’s analysts forecast the global anatomy pathology testing market to grow at a CAGR of 8.26% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global anatomy pathology testing market for 2017-2021. To calculate the market size, the report considers the revenue generated from anatomy pathology testing.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Anatomic Pathology Testing Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Abbott Diagnostics
• Agilent Technologies
• Danaher
• Roche Diagnostics
• Thermo Fisher Scientific
Other prominent vendors
• 20/20 GeneSystems
• Abcam
• AdnaGen
• Advanced Cell Diagnostics
• Agendia
• Angsana Molecular & Diagnostics Laboratory
• AutoGenomics
• Biocare Medical
• Biocartis
• CellMax Life
• Cancer Genetics
• Digipath
• Enzo Biochem
• Epic Sciences
• Janssen Diagnostic
• Monogram Biosciences
• Nucleix
• Omnyx
• Oxford Cancer Biomarkers
• RareCyte
• SAKURA FINETEK USA
• Tecan
• VolitionRx
Market driver
• Growing prevalence of cancer in demographics
• For a full, detailed list, view our report
Market challenge
• High initial investment and maintenance costs
• For a full, detailed list, view our report
Market trend
• Presence of venture capitalists in market
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
